My daughter was recently identified as likely having arthrogryposis. We had initially been told it might just be club hands and feet — isolated orthopedic findings that are often very treatable on their own. The broader diagnosis came later, and with it a steep learning curve. This post is my attempt to lay out what I’ve pieced together about the condition, how the diagnostic picture has evolved, and what the medical roadmap looks like from here. I’m writing this partly to organize the story for myself and partly in case it’s useful to other parents navigating something similar.

From Club Hands and Feet to Arthrogryposis

Clubfoot (talipes equinovarus) and clubhand describe what you can see — a limb held in an abnormal position at birth. These can occur on their own and are often correctable with serial casting, bracing, and sometimes minor surgery.

Arthrogryposis is a different kind of label. It doesn’t describe the appearance of one limb; it describes why multiple joints are stiff. The full term is Arthrogryposis Multiplex Congenita (AMC), meaning “multiple congenital joint contractures.” A contracture is a joint with permanently restricted range of motion present from birth. When a baby has stiffness in multiple joints — as my daughter does, in both her hands and both her feet, along with bilateral hip dislocation — clinicians begin to consider AMC as the underlying explanation.

AMC is not a single disease. It’s an umbrella covering more than 300 subtypes with different causes, prognoses, and treatment paths. The diagnostic work is figuring out which subtype is in play, because the answer drives almost everything else.

Why Fetal Movement Is the Central Concept

Joints form normally only when a fetus moves them. Active fetal movement during the second trimester is what shapes the joint capsule, sets tendon and ligament length, and develops the muscle bulk needed for functional positioning after birth.

When fetal movement is reduced or absent — for any reason — the affected joints develop contractures. The cascade looks like this:

1. Something disrupts the fetal motor system (nerve, muscle, or connective tissue)
2. The fetus moves less than normal
3. Joints that don’t get moved develop abnormally
4. The baby is born with multiple stiff joints

This is why AMC has so many subtypes. Anything that reduces fetal movement can cause it. The diagnostic puzzle is identifying which upstream cause is responsible.

The Mechanistic Categories

AMC subtypes group into roughly five mechanisms:

Neurogenic causes — Problems with the motor neurons or nerves signaling muscles to move. The classic example is amyoplasia, where motor neurons in the spinal cord (anterior horn cells) are thought to be damaged during early development.

Myopathic causes — Problems with the muscle itself. Many distal arthrogryposis subtypes fall here, often caused by mutations in genes coding for muscle contractile proteins.

Connective tissue causes — Abnormal development of joint capsule, tendon, or ligament structures.

Mechanical/uterine causes — Physical restriction of fetal movement from uterine malformations, low amniotic fluid, or multiple gestation crowding.

Maternal factors — Antibodies crossing the placenta, certain medications, or maternal illness.

Identifying which category applies requires combining physical examination, genetic testing, sometimes EMG or muscle biopsy, and importantly — a careful review of the prenatal history.

Amyoplasia: The Most Common Subtype

Amyoplasia accounts for roughly 40% of AMC cases and is the prototype most clinicians have in mind when they say “classic arthrogryposis.” It has a recognizable signature:

• Symmetric involvement of all four limbs
• Internally rotated shoulders, extended elbows, flexed wrists
• Hips often dislocated, clubfeet
• Cylindrical limbs with reduced muscle bulk and dimpling over joints
• A small forehead hemangioma (vascular birthmark) present in approximately 70% of cases
• Normal facial features otherwise
• Normal cognition
• Non-progressive — does not get worse over time

The word “amyoplasia” literally means “no muscle formation.” On muscle biopsy, affected muscles show fatty and fibrous tissue replacement rather than normal muscle structure.

My daughter has the forehead hemangioma. She has symmetric four-limb involvement. Her hips are out of socket bilaterally. Her shoulders look fine. Her genetic panel came back negative. On its face, the picture lined up very cleanly with classical amyoplasia.

The Anterior Horn Cell Theory

The leading explanation for amyoplasia involves the anterior horn cells — motor neurons sitting in the front portion of the spinal cord’s gray matter. These cells are the final pathway for voluntary movement: signals from the brain travel down the cord, synapse onto anterior horn cells, and those cells send axons out to the muscles. Lose the anterior horn cell, lose the muscle’s ability to contract.

The hypothesis is that during a critical window of fetal development — roughly 8 to 12 weeks gestational age — something disrupts the anterior horn cells in specific regions of the spinal cord. The disruption is patchy and tends to affect the cervical and lumbar enlargements (the segments supplying the arms and legs respectively). This explains why amyoplasia affects all four limbs while sparing the trunk.

When those motor neurons die or fail to develop properly, the muscles they would have innervated never receive normal signals. The muscle tissue that should be there is replaced by fatty and fibrous tissue. The joints those muscles would have moved don’t move, and contractures form.

Vascular Disruption as the Likely Trigger

The most widely accepted hypothesis for what damages the anterior horn cells in the first place is vascular disruption — a transient interruption of blood supply to specific regions of the developing spinal cord. Several lines of evidence support this:

The forehead hemangioma found in classical amyoplasia is itself a vascular anomaly. The strong association between amyoplasia and this specific birthmark in this specific location suggests both findings stem from the same underlying vascular event — one affecting spinal cord perfusion, the other affecting facial vasculature.

Twin pregnancies have an elevated rate of amyoplasia, particularly when there’s evidence of co-twin loss or shared circulation problems. The death of one twin can cause significant hemodynamic disturbance in the surviving fetus, including transient hypoperfusion of vulnerable developing tissues.

The patchy, symmetric distribution is consistent with watershed-area vulnerability — specific regions of the developing spinal cord most susceptible to brief perfusion drops.

The non-progressive nature fits a one-time injury rather than an ongoing disease process. A vascular event happens, it causes damage, and then it’s done. The damage is set; the spinal cord doesn’t continue to deteriorate.

The sporadic occurrence is also consistent with a vascular mechanism. Such events during fetal development are typically random — not inherited, not predictable, and unlikely to recur in subsequent pregnancies. This is why the recurrence risk for amyoplasia in future pregnancies is essentially baseline population risk.

Our Prenatal History

This is where the picture got more interesting for us. Early in my wife’s pregnancy, she experienced significant bleeding — enough that we thought we had miscarried. An ultrasound assessment afterward showed the pregnancy was still proceeding. Later in the pregnancy, my wife developed a hematoma, and that contributed to placenta previa.

What I’ve learned since is that the bleeding pattern we experienced is the classic presentation of vanishing twin syndrome. Studies suggest up to 20-30% of twin pregnancies actually start as twins and one is lost in the first trimester, often before twin gestation is confirmed by ultrasound. The surviving twin continues developing, but the vascular event of the co-twin’s demise can transiently affect perfusion to the survivor. Without an ultrasound in the earliest weeks, a twin can be present and lost without ever being documented.

A subchorionic hematoma — a collection of blood between the placenta and uterine wall — has its own implications. Large hematomas can compromise placental blood flow, release inflammatory mediators affecting fetal development, and create intermittent hypoperfusion episodes during exactly the developmental window when motor neurons are vulnerable.

Placenta previa — when the placenta implants over or near the cervix — is frequently associated with abnormal placental vascular development. This can produce repeated episodes of bleeding and reduced fetal perfusion throughout pregnancy.

Stacked together — a likely vanishing twin event, a subchorionic hematoma, and placenta previa — our pregnancy had multiple vascular disruption events that line up with what the amyoplasia theory predicts must occur to cause the condition. This is consistent with my daughter’s negative genetic testing. If the underlying cause is a developmental vascular event rather than a genetic mutation, there’s nothing for a gene panel to find.

The Wrinkle: Extended Features

My daughter’s presentation has some features that go beyond classical amyoplasia. She has micrognathia — a small, recessed lower jaw. At birth she was observed to have a cleft palate, though it was no longer visible on a follow-up exam a couple of weeks later. She has feeding weakness — she can breastfeed, but only with a plastic nipple shield, and growth has been on the slow side of acceptable. Her sleep, breathing, and overall medical stability are good.

These additional findings matter because classical amyoplasia from spinal anterior horn injury shouldn’t easily affect jaw development. Jaw muscles are innervated by cranial nerves originating in the brainstem, not the spinal cord. A purely regional spinal cord event shouldn’t produce micrognathia.

That opens two possibilities:

Extended or atypical amyoplasia from a more severe vascular event. If the underlying disruption was significant enough — and our prenatal history suggests it may have been — it could have affected brainstem motor nuclei in addition to spinal anterior horn cells. This would explain the limb pattern, the hemangioma, the micrognathia, the possible palatal involvement, and the feeding weakness as parts of one broader vascular-mechanism picture.

A syndromic distal arthrogryposis. Conditions like Sheldon-Hall syndrome (DA2B) feature multi-joint contractures with micrognathia and sometimes cleft palate, generally with normal cognition and favorable ambulatory outcomes. These are typically genetic, often involving mutations in MYH3, TNNI2, TNNT3, or TPM2. Whether her targeted panel covered all of these — and whether broader testing like whole exome sequencing or trio testing (testing both parents in addition to the child) would add anything — is a question I plan to bring back to the geneticist.

The cleft palate observation is also worth revisiting. True cleft palates don’t resolve on their own. The most likely explanations for what was observed are a high-arched palate that was initially misread, a submucous cleft where the surface tissue is intact but the underlying muscle is split, or a bifid uvula. Any of these is consistent with the broader picture.

The Diagnostic Workup

For a baby presenting with possible AMC, the standard workup typically includes:

Physical examination — Distribution of contractures, presence of hemangioma, facial features, muscle bulk, and tone. An experienced pediatric orthopedist or geneticist can often narrow the differential significantly from physical findings alone.

Genetic testing — Usually starts with a targeted arthrogryposis gene panel covering the most common distal arthrogryposis genes. If this is negative and the phenotype is complex, expanding to whole exome sequencing — ideally trio testing including both parents — may be appropriate.

Imaging — Hip ultrasound or X-ray to assess for dislocation, spinal imaging if indicated, sometimes brain MRI if central nervous system involvement is suspected.

Prenatal history review — Detailed review of bleeding episodes, hematomas, placental abnormalities, ultrasound findings, and any pregnancy complications. In our case this is doing a lot of explanatory work.

EMG and muscle biopsy — Reserved for cases where distinguishing neurogenic from myopathic mechanism would change management. Not always pursued if the clinical picture is clear.

Multidisciplinary evaluation — Pediatric orthopedics, medical genetics, often a craniofacial team if jaw or palate involvement is present, sometimes pulmonology if there are feeding or breathing concerns.

For families whose child has any craniofacial findings, a craniofacial team referral is high-value early. They handle the combination of feeding support, palate monitoring, jaw growth tracking, and future orthognathic planning.

What Treatment Looks Like

The treatment approach for AMC is similar across most subtypes in the first months of life, which means aggressive early intervention can begin before subtype is fully clarified.

Physical therapy and occupational therapy are initiated as early as possible. The first 6-12 months represent the highest-leverage window because connective tissue is most pliable in infancy. Passive range-of-motion work, stretching, and positioning can produce dramatic gains during this period.

Serial casting is the standard for clubfeet. The Ponseti method (developed by Dr. Ignacio Ponseti) involves sequential casts that gradually correct foot position, followed by a final Achilles tenotomy and long-term bracing. AMC clubfeet are stiffer than idiopathic clubfeet and often need more casts and a higher rate of tendon release, but the method works.

Hip management has evolved. Bilateral hip dislocation is common in amyoplasia (60-80% of cases). Many centers now leave bilateral dislocations unreduced if they’re not painful, because the surgical morbidity often outweighs functional benefit. Many children walk on dislocated hips. Unilateral dislocations are more often surgically addressed to prevent asymmetry. The right approach is an active discussion to have with the orthopedic team.

Orthotics become part of long-term mobility. AFOs (ankle-foot orthoses) and sometimes KAFOs (knee-ankle-foot orthoses, which include the knee) are custom-fitted by a pediatric orthotist and replaced as the child grows. Some children reduce or stop bracing as they grow; others use them long-term.

Upper extremity surgery is often timed for ages 1-4. Procedures may include posterior elbow capsulotomy, triceps lengthening, or humeral osteotomy to improve hand-to-mouth function. Wrist procedures sometimes come later. The single most important functional goal is hand-to-mouth capability for independent feeding.

Feeding support ranges from nipple shields and bottle modifications to temporary nasogastric or gastrostomy tube support, depending on severity. Most children transition off supplemental feeding as oral skills strengthen.

Craniofacial monitoring continues throughout childhood when micrognathia is present, tracking jaw growth, palate function, and the potential need for orthognathic surgery later.

Anesthesia considerations matter for any future surgery. Micrognathia makes intubation harder, so the anesthesia team should be aware in advance. Some genetic AMC subtypes carry malignant hyperthermia risk (particularly MYH3-associated forms), which is also worth flagging if relevant.

What Outcomes Look Like

For children with amyoplasia or a related vascular-etiology AMC, the outcome data is reasonably encouraging when aggressive early intervention is in place:

Ambulation — Approximately 75-85% of children with classical amyoplasia achieve independent walking, often with bracing. Distal arthrogryposis subtypes generally do even better.

Upper extremity function is the harder battle. The goal is typically adapted independence — feeding, dressing, writing or typing with modifications — rather than typical range of motion. Children develop compensatory strategies that often surprise outside observers.

Cognition is normal in amyoplasia and most distal arthrogryposis subtypes. AMC is fundamentally a motor condition.

Independence — Most adults with amyoplasia live independently, work, drive (often with adaptations), and have families.

Long-term considerations — Adolescent growth spurts can cause contractures to recur or worsen as rapid bone growth outpaces tendon length. Additional surgeries in the 10-14 age range are common. Adult joint wear from non-standard joint alignment may lead to earlier arthritis in some joints, an area receiving more attention as the first generation of well-treated AMC patients reaches middle age.

The Roadmap From Here

For a family at the beginning of the AMC journey, the timeline roughly follows this arc:

First year — Aggressive PT/OT, serial casting if applicable, feeding support, hip management decisions, genetic workup, establishment of the multidisciplinary care team. This is the highest-leverage intervention window.

Ages 1-3 — Upper extremity surgical decisions, continued therapy, mobility assessment, enrollment in early intervention services, beginning of self-care skill development.

Ages 3-5 — Transition from early intervention to school-based services, IEP development, walking pattern maturation, adaptive equipment refinement.

School age — Ongoing therapy at reduced frequency, school accommodations, sometimes additional orthopedic procedures.

Adolescence — Growth-related contracture recurrence may require additional surgery. Identity development around disability. Increasing independence in self-management.

Adulthood — Vocational planning, independent living, monitoring for early joint wear, ongoing physical maintenance.

Practical Observations

A few things worth noting from what I’ve learned:

Specialized centers matter. Pediatric orthopedic departments with dedicated AMC clinics — Shriners Hospitals, Texas Scottish Rite, Boston Children’s, Seattle Children’s, Nemours, among others — handle enough volume to make calibrated decisions about surgical timing and approach. The difference between a general pediatric orthopedist and an AMC specialist is meaningful.

Connection to other families helps. AMCSI (Arthrogryposis Multiplex Congenita Support, Inc.) runs an annual conference and family forums where practical knowledge gets shared that doesn’t appear in medical literature.

Documentation is its own discipline. Care for AMC involves many specialists over many years. Organized records of imaging, surgical reports, therapy notes, and equipment specifications make a difference over the long arc.

The prenatal history can do real explanatory work. In our case, the combination of likely vanishing twin, subchorionic hematoma, and placenta previa appears to supply a coherent vascular explanation for our daughter’s condition without requiring a genetic cause. This is consistent with her negative genetic testing and reduces concerns about recurrence in future pregnancies, since vascular events of this type are typically sporadic rather than inherited.

Where We Stand

The working picture for my daughter is an extended or atypical amyoplasia with a vascular etiology supported by the prenatal history. Whether additional genetic testing might still uncover a contributing factor is an open question I plan to revisit with the genetics team. Either way, the first-year priorities — aggressive PT/OT, feeding support, hip and clubfoot decisions, craniofacial team involvement, and establishing the long-term care team — are the same.

The medical complexity is real. The outlook with current care standards is meaningfully better than even one generation ago. The trajectory from here is one we can plan thoughtfully rather than react to in crisis mode, which is the situation I’d rather be in than the alternative.